Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lifemd Inc (LFMD)

Lifemd Inc (LFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 331,554
  • Shares Outstanding, K 42,290
  • Annual Sales, $ 152,550 K
  • Annual Income, $ -20,600 K
  • 60-Month Beta 1.38
  • Price/Sales 2.11
  • Price/Cash Flow N/A
  • Price/Book 246.80
Trade LFMD with:

Options Overview Details

View History
  • Implied Volatility 68.16% ( +0.31%)
  • Historical Volatility 103.12%
  • IV Percentile 3%
  • IV Rank 13.25%
  • IV High 210.26% on 06/20/23
  • IV Low 46.45% on 08/07/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 902
  • Volume Avg (30-Day) 1,344
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 12,207
  • Open Int (30-Day) 15,250

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.14
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +43.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.53 +3.19%
on 05/20/24
12.88 -39.67%
on 05/07/24
-4.18 (-34.98%)
since 04/26/24
3-Month
7.09 +9.59%
on 03/05/24
12.88 -39.67%
on 05/07/24
-0.23 (-2.88%)
since 02/28/24
52-Week
1.93 +302.59%
on 05/31/23
12.88 -39.67%
on 05/07/24
+5.59 (+256.42%)
since 05/26/23

Most Recent Stories

More News
LifeMD, Inc. to Present at the June 1st Virtual Investor Summit

New York, New York--(Newsfile Corp. - May 23, 2023) - LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the virtual...

LFMD : 7.77 (-0.89%)
LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 88.89% and 2.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LFMD : 7.77 (-0.89%)
SLHGF : 0.0001 (-96.77%)
Life Time Group Holdings, Inc. (LTH) Reports Q3 Loss, Lags Revenue Estimates

Life Time Group Holdings, Inc. (LTH) delivered earnings and revenue surprises of 22.22% and 0.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

LTH : 15.64 (-3.75%)
LFMD : 7.77 (-0.89%)
Charles River Laboratories (CRL) Tops Q3 Earnings and Revenue Estimates

Charles River (CRL) delivered earnings and revenue surprises of 4.78% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CRL : 214.51 (-1.24%)
LFMD : 7.77 (-0.89%)
LifeMD, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 11, 2022

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it...

LFMDP : 21.90 (+4.53%)
LFMD : 7.77 (-0.89%)
LifeMD, Inc. (LFMD) Upgraded to Buy: Here's Why

LifeMD, Inc. (LFMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LFMD : 7.77 (-0.89%)
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, June 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its...

LFMD : 7.77 (-0.89%)
LFMDP : 21.90 (+4.53%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

ACST : 2.63 (-3.31%)
LPTH : 1.3000 (+0.78%)
RCAT : 0.9902 (-3.40%)
IONM : 0.4473 (+3.95%)
PYR : 0.3799 (unch)
OSS : 2.44 (+0.83%)
MODD : 1.5800 (-0.63%)
STRN : 1.3400 (+0.75%)
AEYE : 24.00 (+0.08%)
SMFL : 3.35 (+9.12%)
LFMD : 7.77 (-0.89%)
SURG : 3.83 (-2.54%)
LifeMD, Inc. (LFMD) Reports Q1 Loss, Misses Revenue Estimates

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 3.85% and 6.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

LFMD : 7.77 (-0.89%)
SLHG : 0.5847 (-1.75%)
LifeMD, Inc. Reports First Quarter 2022 Results

First quarter 2022 consolidated revenue of $29.0 million up 60% from the same year ago period.Adjusted EPS of $(0.25), 14% sequential improvement versus...

LFMDP : 21.90 (+4.53%)
LFMD : 7.77 (-0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer...

See More

Key Turning Points

3rd Resistance Point 8.23
2nd Resistance Point 8.12
1st Resistance Point 7.94
Last Price 7.77
1st Support Level 7.65
2nd Support Level 7.54
3rd Support Level 7.36

See More

52-Week High 12.88
Fibonacci 61.8% 8.70
Last Price 7.77
Fibonacci 50% 7.41
Fibonacci 38.2% 6.11
52-Week Low 1.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar